The duration of in vitro stimulation with recall antigens determines the subset distribution of interferon-gamma-producing lymphoid cells: a kinetic analysis using the Interferon-gamma Secretion Assay.
Analyses of cellular immune responses during natural infections and following vaccination with established or candidate vaccines are becoming increasingly important and so are the research tools used to achieve this goal. During a recent evaluation of the analytical performance characteristics of one of these techniques, the interferon-gamma secretion assay, we noticed that following overnight incubation of PBMC with recall antigens (varicella-zoster antigen, Candida albicans antigen or hepatitis B surface antigen) NK cells are frequently the most predominant interferon-gamma-producing cell population. In this study, we monitored the subset distribution of interferon-gamma-producing cells following more extended in vitro culture periods and found that, irrespective of the antigen applied, the contribution of NK cells decreased whereas the importance of T cells and NKT cells rose. Analysis of the subset distribution showed that HBsAg stimulated CD4 cells predominantly whereas Candida antigen and varicella-zoster antigen were better inducers of CD8 responses. No correlation was found between the kinetics of total number of interferon-gamma-producing cells and the changes of concentrations of interferon-gamma in the culture supernatants. Interferon-gamma levels in culture supernatants correlated strongly with the kinetics of T(H) lymphocytes (CD3+, CD4+), CTL (CD3+, CD8+), and NKT cells (CD3+, CD56+). These observations lead us to conclude that methods that enumerate cytokine-secreting cells without determining their phenotype should be interpreted with great care and that an 'elispot' should not be directly considered as the footprint of a T lymphocyte.
Center for Vaccinology, Department Clinical Biology, Microbiology and Immunology, Ghent University and Hospital, De Pintelaan, 185, 9000 Ghent, Belgium. isabelle.desombere@ugent.be
I
I
Desombere
F
F
Clement
H
H
Rigole
G
G
Leroux-Roels
D000941:Antigens / Q000276:immunology*; D002176:Candida albicans / Q000276:immunology; D002478:Cells, Cultured; D014645:Herpesvirus 3, Human / Q000276:immunology; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis / Q000378:metabolism*; D007700:Kinetics; D008214:Lymphocytes / Q000276:immunology* / Q000378:metabolism*; D010641:Phenotype; D013997:Time Factors
D000941:Antigens; D007371:Interferon-gamma